Execs On The Move, December 2015

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

New At The Helm

Company Changes

AFDHAL, Nezam, MD

To: Spring Bank Pharmaceuticals Inc., CMO (November)

From:Consultant

Phone:[phone]

BARBOSA, Miguel, PhD

To: Mirna Therapeutics Inc., EVP, CSO (October)

From:Johnson & Johnson Innovation, Executive in Residence

Phone:[phone]

BOUDREZ, Steven

To: TransEnterix Inc., VP, Sales, Europe (November)

From:MedTech SA, VP, Sales, Europe

Phone:[phone]

BOYCE, John

To: Exosome Diagnostics Inc., CEO (November)

From:GnuBIO Inc., CEO

Phone:[phone]

BREWIS, Neil, PhD

To: F-star Biotechnology Ltd., CSO (November)

From:GlaxoSmithKline PLC, VP, Head, Biopharmaceutical Research

Phone:[phone]

BURKE, Michael K.

To: EndoGastric Solutions Inc., CFO (November)

From:Landauer Inc., SVP, CFO

Phone:[phone]

CLEVELAND, Paul B.

To: Avalanche Biotechnologies Inc., CEO (December)

From:Celladon Corp., CEO

Phone:[phone]

COLONNESE, Mark P.

To: Biota Pharmaceuticals Inc., EVP, CFO (November)

From:Stealth BioTherapeutics Inc., CFO

Phone:[phone]

CORIC, Vlad, MD

To: Biohaven Pharmaceutical Holding Co., CEO (November)

From:Bristol-Myers Squibb Co., Neuro-Oncology Indication Lead, Immuno-Oncology

Phone:[phone]

DU, Zhengming, PhD

To: BeiGene (Beijing) Co. Ltd., SVP, Head, Chemistry & Mfg. Controls (November)

From:Roche Pharmaceuticals, China, Dir. & Head, Process Research & Synthesis

Phone:[phone]

FITTS, David, PhD

To: Medgenics Inc., VP, Head, Statistical Science & Data Mgmt. (October)

From:ViroPharma Inc., Head, Biometrics

Phone:[phone]

FRANCOIS, Eric

To: Scynexis Inc., CFO (November)

From:Topi Inc., COO

Phone:[phone]

FROST, Mark

To: Analogic Corp., SVP, CFO (November)

From:AngioDynamics Inc., EVP, CFO

Phone:[phone]

GLADNEY, Dan

To: EnteroMedics Inc., Pres. & CEO (November)

From:Lanx Inc., CEO

Phone:[phone]

GUIRAKHOO, Farshad, PhD

To: GeoVax Labs Inc., SVP, R&D (October)

From:Vaxess Technologies Inc., CTO

Phone:[phone]

GUNDOTRA, Vic

To: AliveCor Inc., CEO (November)

From:Google, SVP

Phone:[phone]

HAGUE, Richard

To: Anika Therapeutics Inc., Chief Commercial Officer (October)

From:TEI Medical Inc., VP, Sales& Mktg.

Phone:[phone]

HAWTHORNE, Donald B.

To: Daktari Diagnostics Inc., Pres. & CEO (October)

From:AdvanDx Inc., Pres. & CEO

Phone:[phone]

HEI, Yong-Jiang, MD, PhD

To: Ambrx Inc., CMO (November)

From:Amgen Inc., Exec. Medical Dir., Global Dev.

Phone:[phone]

HERMANN, Volker, MD

To: Viamet Pharmaceuticals Inc., Chief Commercial Officer (November)

From:Pfizer Inc., Head, Global Strategy, Commercial Dev. & Global Mktg., Vaccines

Phone:[phone]

IBRAHIM, Prabha N., PhD

To: Afferent Pharmaceuticals Inc., CTO (November)

From:Plexxikon Inc., SVP, Chemistry& Non-Clincal Dev.

Phone:[phone]

KOGL, Jeff

To: Entellus Medical Inc., VP, Bus. Dev. & Strategy (October)

From:Tornier, VP, Strategy & Corp. Dev.

Phone:[phone]

LIN, Jimmy, MD, PhD

To: Natera Inc., CSO, Oncology (November)

From:National Cancer Institute, Head, Clinical Genomics Program

Phone:[phone]

MANTUS, David, PhD

To: Arsanis Inc., EVP, Regulatory Affairs, Clin. & Technical Ops. (November)

From:Bind Therapeutics Inc., VP, Regulatory Affairs & Quality Assurance

Phone:[phone]

MARTIN-LOF, Anders

To: Wilson Therapeutics AB, CFO (November)

From:Extenda, CFO

Phone:[phone]

MOTHERAM, Rajeshwar, PhD

To: Scynexis Inc., VP, Pharmaceutical Dev. (October)

From:The Medicines Co., VP, Pharmaceutical Dev.

Phone:[phone]

PETERSEN-JAPPELLI, AnnKatrin, MD

To: Ritter Pharmaceuticals Inc., CMO (October)

From:Santarus Inc., Advisor, Scientific Res. &Clin. Dev. Leader, Rifamycin SV MMX

Phone:[phone]

RAY, Nitya G., PhD

To: CytoDyn Inc., SVP, Mfg. (November)

From:Progenics Pharmaceuticals Inc., SVP

Phone:[phone]

SCHOPF, Lisa Rae, PhD

To: Vedanta Biosciences, Head, Preclinical Dev. (October)

From:Kala Pharmaceuticals Inc., Senior Dir., Preclinical Dev.

Phone:[phone]

SHAZER, Ronald, MD

To: Tracon Pharmaceuticals Inc., CMO (October)

From:Pfizer Inc., Senior Dir., Clin. Lead, Oncology

Phone:[phone]

SKIBSTED, Russell

To: BioTime Inc., CFO (November)

From:Proove Biosciences, CFO

Phone:[phone]

SPEK, Erik J., PhD

To: Vedanta Biosciences, Head, Intellectual Property (October)

From:Epizyme Inc., Director, IP

Phone:[phone]

SQUIRES, Liza, MD

To: Medgenics Inc., VP, R&D, Therapeutic Area Head, Neuroscience (October)

From:Lumos Pharma Inc., CMO

Phone:[phone]

SU, Jeffrey, PhD

To: Sorrento Therapeutics Inc., COO (October)

From:Cytovance Biologics Inc., Chief Scientific & Dev. Officer

Phone:[phone]

TREHU, Elizabeth, MD

To: Jounce Therapeutics Inc., CMO (November)

From:Promedior Inc., CMO

Phone:[phone]

WASIEWSKI, Warren, MD

To: BioBlast Pharma Ltd., CMO & VP, R&D (November)

From:NeurotropeBioScience, CMO & EVP, Clin. Dev.

Phone:[phone]

YUAN, RuiRong, MD

To: BeiGene (Beijing) Co. Ltd., CMO & Pres., Global Clin. Dev. (November)

From:Eisai Global Oncology, CMO, Head, Americas Oncology Med. Research & Strategy

Phone:[phone]

Directors

COOPER, Warren D.

To: Zynerba Pharmaceuticals Inc., Lead Independent Director (November)

Phone:[phone]

FINNEY, Kevin

To: Taris Biomedical Inc., Director (November)

Phone:[phone]

GREENLEAF, Peter

To: Mast Therapeutics Inc., Director (November)

Phone:[phone]

GREER, R. Scott

To: Calimmune Inc., Chairman (November)

Phone:[phone]

IWICKI, Mark

To: TarisBiomedical Inc., Director (November)

Phone:[phone]

KINGSLEY, S. Anthony

To: Proteon Therapeutics Inc., Director (October)

Phone:[phone]

KUPFER, David J., MD

To: Minerva Neurosciences Inc., Director (November)

Phone:[phone]

MORFIT, G. Mason

To: Valeant Pharmaceuticals International Inc., Director (October)

Phone:[phone]

NOVA, Tina S., PhD

To: Veracyte Inc., Director (November)

Phone:[phone]

PAULS, Matthew

To: Mast Therapeutics Inc., Director (November)

Phone:[phone]

ROSENTHAL, Robert, PhD

To: BrukerBioSciences Corp., Director (November)

Phone:[phone]

SLACIK, Charles P.

To: Quidel Corp., Director (November)

Phone:[phone]

SULLIVAN, James, PhD

To: Calimmune Inc., Director (November)

Phone:[phone]

WALBERT, Timothy P.

To: Sucampo Pharmaceuticals Inc., Director (October)

Phone:[phone]

Promotions

BIONDI, Paul

To: Bristol-Myers Squibb Co.

New Title:SVP, Head, Bus. Dev. (October)

Previous Title:SVP, Head, R&D Ops.

Phone:[phone]

BIRKETT, Bernard

To: Merit Medical Systems Inc.

New Title:CFO (November)

Previous Title:VP, International Finance

Phone:[phone]

EWERS, Jay

To: Bovie Medical Corp.

New Title:CFO (October)

Previous Title:Interim CFO

Phone:[phone]

KAPOOR, John, PhD

To: Insys Therapeutics Inc.

New Title:Chairman, Pres. & CEO (November)

Previous Title:Chairman

Phone:[phone]

SAPAN, Christine V., PhD

To: Asana Medical Inc.

New Title:Pres.

Previous Title:EVP, R&D

Phone:[phone]

Resignations

RADVANYI, Laszlo

From: Lion Biotechnologies Inc., CSO (November)

Phone:[phone]

ROMBACH, W. Scott

From: CompuMed Inc., Pres. & CEO (November)

Phone:[phone]